Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma-1b + Chemo in Ovarian Cancer
NCT00047632Phase 3Terminated
- Sponsor
- InterMune
- Start
- Oct 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon gamma-1b in ovarian carcinoma, primary peritoneal carcinoma (PPC), sponsored by InterMune. Started Oct 2001; status: terminated.
02
Drugs
interferon gamma-1b
03
Conditions
ovarian carcinomaprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00047632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047632.